VCIM
Velan Capital Investment Management Portfolio holdings
AUM
$99.9M
This Quarter Return
+3.84%
1 Year Return
+37.46%
3 Year Return
+659.14%
5 Year Return
–
10 Year Return
–
AUM
$85.4M
AUM Growth
+$85.4M
(-9.4%)
Cap. Flow
-$10.6M
Cap. Flow
% of AUM
-12.37%
Top 10 Holdings %
Top 10 Hldgs %
85.17%
Holding
30
New
6
Increased
6
Reduced
4
Closed
5
Top Buys
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$4.08M |
| 2 |
Healthcare Services Group
HCSG
|
$2.74M |
| 3 |
TELA Bio
TELA
|
$2.11M |
| 4 |
QIPT
Quipt Home Medical
QIPT
|
$2.08M |
| 5 |
Zymeworks
ZYME
|
$1.45M |
Top Sells
| 1 |
RDUS
Radius Health, Inc.
RDUS
|
$18.4M |
| 2 |
Lantheus
LNTH
|
$4.83M |
| 3 |
ADMA Biologics
ADMA
|
$1.95M |
| 4 |
Caribou Biosciences
CRBU
|
$1.14M |
| 5 |
SNCE
Science 37 Holdings, Inc. Common Stock
SNCE
|
$441K |
Sector Composition
| 1 | Healthcare | 98.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Lantheus
LNTH
$3.73B
| $14.1M | 13.95% | 200,000 -68,658 | -26% | -$4.83M |
|
2
Immunocore
IMCR
$1.62B
| $13.8M | 13.66% | 293,385 | – | – |
|
|
3
ADMA Biologics
ADMA
$4.12B
| $12.8M | 12.7% | 5,269,155 -804,443 | -13% | -$1.95M |
|
|
OPTN
4
DELISTED
OptiNose
OPTN
| $7.97M | 7.9% | 2,176,572 +176,572 | +9% | +$646K |
|
|
5
TELA Bio
TELA
$70.5M
| $6.36M | 6.31% | 746,087 +247,849 | +50% | +$2.11M |
|
|
6
Healthcare Services Group
HCSG
$1.13B
| $4.84M | 4.8% | 400,000 +227,000 | +131% | +$2.74M |
|
|
HZNP
7
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $4.26M | 4.23% | 68,829 +65,862 | +2,220% | +$4.08M |
|
|
QIPT
8
Quipt Home Medical
QIPT
$114M
| $3.34M | 3.31% | 800,000 +497,900 | +165% | +$2.08M |
|
9
BioCryst Pharmaceuticals
BCRX
$1.74B
| $2.84M | 2.81% | 225,000 | – | – |
|
10
The Oncology Institute
TOI
$318M
| $2.54M | 2.52% | 548,841 -51,159 | -9% | -$237K |
|
11
Jasper Therapeutics
JSPR
$45.5M
| $2.24M | 2.22% | 3,219,036 | – | – |
|
|
12
Zymeworks
ZYME
$1.12B
| $1.45M | 1.43% | +234,902 | New | +$1.45M |
|
13
Sonida Senior Living
SNDA
$488M
| $1.35M | 1.33% | 82,832 | – | – |
|
|
ALIM
14
DELISTED
Alimera Sciences, Inc.
ALIM
| $1.16M | 1.15% | 227,602 +40,601 | +22% | +$206K |
|
15
Rezolute
RZLT
$619M
| $1.1M | 1.09% | 400,000 | – | – |
|
|
BLU
16
DELISTED
BELLUS Health Inc.
BLU
| $1.06M | 1.05% | +100,000 | New | +$1.06M |
|
|
CFMS
17
DELISTED
Conformis, Inc. Common Stock
CFMS
| $986K | 0.98% | 5,156,406 | – | – |
|
18
Xenon Pharmaceuticals
XENE
$2.98B
| $722K | 0.72% | 20,000 | – | – |
|
19
Collegium Pharmaceutical
COLL
$1.22B
| $640K | 0.63% | +39,957 | New | +$640K |
|
|
LMDX
20
DELISTED
LumiraDx Limited Common Shares
LMDX
| $583K | 0.58% | +571,428 | New | +$583K |
|
21
Assertio
ASRT
$80.4M
| $533K | 0.53% | +234,766 | New | +$533K |
|
|
NYXH
22
Nyxoah
NYXH
$234M
| $498K | 0.49% | 79,021 -11,976 | -13% | -$75.5K |
|
23
Glaukos
GKOS
$5.5B
| $367K | 0.36% | +6,896 | New | +$367K |
|
|
24
Caribou Biosciences
CRBU
$174M
| – | – | -210,695 | Closed | -$1.14M |
|
25
SPDR Euro Stoxx 50 ETF
FEZ
$4.54B
| – | – | 0 | – | – |
|